Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison
2019-07 | journal article
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Consolidative mediastinal irradiation of malignant lymphoma using active scanning proton beams: clinical outcome and dosimetric comparison
König, L.; Bougatf, N.; Hörner-Rieber, J.; Chaudhri, N.; Mielke, T.; Klüter, S. & Haefner, M. F. et al. (2019)
Strahlentherapie und Onkologie, 195(7) pp. 677-687. DOI: https://doi.org/10.1007/s00066-019-01460-7
Documents & Media
Details
- Authors
- König, Laila; Bougatf, Nina; Hörner-Rieber, Juliane; Chaudhri, Naved; Mielke, Thomas; Klüter, Sebastian; Haefner, Matthias Felix; Rieken, Stefan ; Haberer, Thomas; Debus, Jürgen; Herfarth, Klaus
- Abstract
- Current research approaches in lymphoma focus on reduction of therapy-associated long-term side effects. Especially in mediastinal lymphoma, proton beam radiotherapy (PT) may be a promising approach for reducing the dose to organs at risk (OAR).
- Issue Date
- July-2019
- Journal
- Strahlentherapie und Onkologie
- ISSN
- 0179-7158
- eISSN
- 1439-099X
- Language
- English
